Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide Receptors”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Not applicableUnknownNCT05268627
What this trial is testing

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss

Who this might be right for
Obesity
Mansoura University 38
Testing effectiveness (Phase 2)Looking for participantsNCT07523633
What this trial is testing

Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder

Who this might be right for
Cannabis Use DisorderCannabis Use DisordersCannabis Abuse+2 more
Anders Fink-Jensen, MD, DMSci 100
Not applicableLooking for participantsNCT07027995
What this trial is testing

Food and Fitness With Medicine (FFWM)

Who this might be right for
Cardiovascular Kidney Metabolic SyndromeType 2 Diabetes
Ohio State University 200
Not applicableLooking for participantsNCT07115069
What this trial is testing

Comparison of Body Composition Changes With Weight Loss Interventions

Who this might be right for
Obesity
Vanderbilt University Medical Center 60
Large-scale testing (Phase 3)Study completedNCT02735031
What this trial is testing

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Hypoglycemia
Radboud University Medical Center 10
Not applicableStudy completedNCT03010683
What this trial is testing

Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusCoronary Artery Disease
University of Athens 60
Post-approval studies (Phase 4)UnknownNCT00473733
What this trial is testing

Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2

Who this might be right for
Diabetes Mellitus Type 2
Assaf-Harofeh Medical Center
Not applicableStudy completedNCT01767389
What this trial is testing

Glucagon-like Peptide (GLP) Utilization and Safety

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 1
Post-approval studies (Phase 4)Study completedNCT02639130
What this trial is testing

GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Diabeteszentrum Bad Lauterberg im Harz 67
Not applicableUnknownNCT06388213
What this trial is testing

Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period.

Who this might be right for
Diabetes Mellitus, Type 2AnesthesiaPulmonary Aspiration of Gastric Contents
University Hospital, Geneva 40
Not applicableEnrolling By InvitationNCT06581120
What this trial is testing

GLP_1 RA Ultrasound Study

Who this might be right for
Glucagon Like Peptide-1 (GLP-1Delayed Gastric EmptyingRisk of Aspiration+2 more
Children's Hospital Medical Center, Cincinnati 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06788626
What this trial is testing

Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment

Who this might be right for
Acute Ischemic StrokeLarge Vessel OcclusionNeuroprotective Drugs+1 more
Wei Hu 390
Not applicableStudy completedNCT06774807
What this trial is testing

Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33)

Who this might be right for
Healthy
University of Copenhagen 10
Not applicableLooking for participantsNCT06069622
What this trial is testing

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

Who this might be right for
Overweight and Obesity
Brigham and Women's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03232112
What this trial is testing

Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?

Who this might be right for
Alcohol Dependence, in RemissionAddiction, Alcohol
Anders Fink-Jensen, MD, DMSci 152
Early research (Phase 1)Looking for participantsNCT05202353
What this trial is testing

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

Who this might be right for
Obesity
Boehringer Ingelheim 30
Not applicableLooking for participantsNCT07065383
What this trial is testing

Rebalancing the Fat Content of the Heart and Muscles

Who this might be right for
Diabetes Mellitus Type 2
University of Aberdeen 60
Testing effectiveness (Phase 2)Study completedNCT02838589
What this trial is testing

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers

Who this might be right for
Stroke
Christina Kruuse 30
Large-scale testing (Phase 3)Looking for participantsNCT07282041
What this trial is testing

Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis

Who this might be right for
Intracranial AtherosclerosisStroke, Ischemic
National University of Singapore 130
Post-approval studies (Phase 4)Study completedNCT04881110
What this trial is testing

Liraglutide and Peripheral Artery Disease

Who this might be right for
Type 2 DiabetesPeripheral Arterial Disease
University of Campania Luigi Vanvitelli 60
Load More Results